Clinical Trials Logo

Clinical Trial Summary

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00407121
Study type Interventional
Source Asociación para Evitar la Ceguera en México
Contact
Status Completed
Phase Phase 3
Start date August 2006
Completion date November 2006

See also
  Status Clinical Trial Phase
Recruiting NCT03399175 - Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease N/A
Recruiting NCT05496530 - Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results) N/A
Completed NCT05031143 - Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment Phase 2/Phase 3